ClinicalTrials.gov
public full text
Public Domain
Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Mechanisms and Research Advances in Drug Delivery Systems for Psoriasis and Atopic Dermatitis.#368035
- Immunomodulatory Effects of a Tick Salivary Serpin on Psoriasis-like Inflammation#1166364
- Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis#1163144
- Prolactin Hormone in Oral Lichen Planus#825340
- Predictors of inactive disease and remission in children and young adults with juvenile idiopathic arthritis treated with etanercept.#242258
Record · ID 411324
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive